Literature DB >> 26462484

[Who performs gynecological cytology and how?].

D Schmidt, H H Neumann.   

Abstract

Since 1971 German women aged 20 years and older can annually participate in the gynecological cancer screening program free of charge. As part of this program a cervical smear is taken for testing. The Federal Joint Committee (Gemeinsamer Bundesausschuss, GBA) is planning to change this system so that women aged over 30 years can either choose to continue with annual cytological screening using a cervical smear or can primarily opt for a human papillomavirus (HPV) test every 5 years. Women who are HPV positive will receive a supplementary cytological examination as a triage method. In Germany classification of the cytological results is based on the third revision of the Munich nomenclature (Münchner Nomenklatur, MN III), which has been in operation since 1 January 2015. The number of accredited cytology institutions and of cytologists has changed considerably since 2008. There has been a marked increase in the number of pathologists by 28.4%, which is a promising trend. The number of tests carried out has remained relatively constant; however, an increasing number of tests are now being performed in large laboratories.

Entities:  

Mesh:

Year:  2015        PMID: 26462484     DOI: 10.1007/s00292-015-0103-2

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  11 in total

1.  Liquid-based cytology improves productivity in cervical cytology screening.

Authors:  B Doyle; C O'Farrell; E Mahoney; L Turner; D Magee; D Gibbons
Journal:  Cytopathology       Date:  2006-04       Impact factor: 2.073

Review 2.  Liquid compared with conventional cervical cytology: a systematic review and meta-analysis.

Authors:  Marc Arbyn; Christine Bergeron; Paul Klinkhamer; Pierre Martin-Hirsch; Albertus G Siebers; Johan Bulten
Journal:  Obstet Gynecol       Date:  2008-01       Impact factor: 7.661

3.  Predictive value of the combined p16 and Ki-67 immunocytochemistry in low-grade squamous intraepithelial lesions.

Authors:  Peter Ziemke; Katrin Marquardt; Henrik Griesser
Journal:  Acta Cytol       Date:  2014-10-17       Impact factor: 2.319

4.  HPV L1 detection discriminates cervical precancer from transient HPV infection: a prospective international multicenter study.

Authors:  Grit Mehlhorn; Ellen Obermann; Giovanni Negri; Lukas Bubendorf; Christine Mian; Martin Koch; Heinz Sander; Birgit Simm; Markus Lütge; Zsuzsanna Bánrévi; Anke Weiss; Gieri Cathomas; Ralf Hilfrich; Matthias Wilhelm Beckmann; Henrik Griesser
Journal:  Mod Pathol       Date:  2013-02-15       Impact factor: 7.842

5.  Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology.

Authors:  K Ulrich Petry; Dietmar Schmidt; Sarah Scherbring; Alexander Luyten; Axel Reinecke-Lüthge; Christine Bergeron; Friedrich Kommoss; Thomas Löning; Jaume Ordi; Sigrid Regauer; Ruediger Ridder
Journal:  Gynecol Oncol       Date:  2011-03-21       Impact factor: 5.482

6.  Correlation of immunochemical detection of HPV L1 capsid protein in pap smears with regression of high-risk HPV positive mild/moderate dysplasia.

Authors:  Henrik Griesser; Heinz Sander; Ralf Hilfrich; Bettina Moser; Ulrich Schenck
Journal:  Anal Quant Cytol Histol       Date:  2004-10       Impact factor: 0.302

7.  Using biomarkers as objective standards in the diagnosis of cervical biopsies.

Authors:  Mary T Galgano; Philip E Castle; Kristen A Atkins; William K Brix; Sarah R Nassau; Mark H Stoler
Journal:  Am J Surg Pathol       Date:  2010-08       Impact factor: 6.394

8.  A randomized trial comparing conventional cytology to liquid-based cytology and computer assistance.

Authors:  Stefanie J Klug; Klaus J Neis; Werner Harlfinger; Armin Malter; Jochem König; Sibylle Spieth; Friederike Brinkmann-Smetanay; Friedrich Kommoss; Veronika Weyer; Hans Ikenberg
Journal:  Int J Cancer       Date:  2012-12-14       Impact factor: 7.396

9.  Automation-assisted versus manual reading of cervical cytology (MAVARIC): a randomised controlled trial.

Authors:  Henry C Kitchener; Roger Blanks; Graham Dunn; Lionel Gunn; Mina Desai; Rebecca Albrow; Jean Mather; Durgesh N Rana; Heather Cubie; Catherine Moore; Rosa Legood; Alastair Gray; Sue Moss
Journal:  Lancet Oncol       Date:  2010-12-09       Impact factor: 41.316

10.  Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: results of the PALMS study.

Authors:  Hans Ikenberg; Christine Bergeron; Dietmar Schmidt; Henrik Griesser; Francisco Alameda; Claudio Angeloni; Johannes Bogers; Roger Dachez; Karin Denton; Jalil Hariri; Thomas Keller; Magnus von Knebel Doeberitz; Heinrich H Neumann; Luis M Puig-Tintore; Mario Sideri; Susanne Rehm; Ruediger Ridder
Journal:  J Natl Cancer Inst       Date:  2013-10-04       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.